Medication info

Myungmoon Linagliptin Tablets

Prescription medicationTablet
Ingredient · strength
Linagliptin›5mg / 1 tablet
Manufacturer / importer
Myungmoon Pharmaceutical Co., Ltd.
Appearance
Round film-coated tablets that are bright red in color, with both sides convex and sharp edges.
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201903547 · Approved 2019.05.29

Summary

Main use
Improves blood glucose control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this medicine is 5 mg once daily. It may be taken with or without food. When coadministered with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Ingredients

Manufacturer
Myungmoon Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in type 2 diabetes mellitus

View approved original text

This medication is used to assist in blood sugar control for patients with type 2 diabetes by complementing dietary and exercise therapy. It can be used alone or in combination with other medications, effectively improving blood sugar levels. This medication facilitates blood sugar management, aiding in diabetes treatment.

Dosage and Administration

Adult dosage

The recommended dose of this medicine is 5 mg once daily. It may be taken with or without food. When coadministered with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Precautions

This medication should not be used by patients who have allergic reactions to the active ingredient or any other components. Additionally, it should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Caution is required when used with other medications that can induce hypoglycemia. Particularly, when used in combination with insulin or sulfonylurea drugs, the risk of hypoglycemia may increase, necessitating potential dose adjustments. Experience with this medication in patients with heart failure is limited, so it should be used with caution. If symptoms of acute pancreatitis, such as severe abdominal pain, occur while taking this medication, it should be discontinued immediately and a doctor should be consulted. There is a possibility of developing a skin condition resembling bullous pemphigoid, so if blisters or skin irritation occur, one should promptly inform a doctor and discontinue the medication. This medication is primarily used in patients with type 2 diabetes, and side effects such as hypoglycemia, infections, gastrointestinal disorders, and skin rashes have been reported. Appropriate action should be taken depending on the severity of any side effects that arise. Its use is not recommended during pregnancy or breastfeeding, and especially for pregnant women, consultation with a doctor is essential before use. It is not recommended for children under 10 years of age; however, safety and efficacy have been reported to be similar to adults in adolescents over 10 years. Elderly patients can use this medication without special dose adjustments, but patients with impaired kidney or liver function can also be administered doses without adjustments. In cases of overdose, measures should be taken to prevent absorption of the medication in the gastrointestinal tract while observing clinical symptoms and providing appropriate treatment if necessary. The medication should be stored out of reach of children, and transferring it to another container should be avoided to prevent accidents and degradation of quality.

Side effects

  • hypoglycemia
  • hypertriglyceridemia
  • hyperlipidemia
  • nasopharyngitis
  • hypersensitivity
  • angioedema
  • urticaria
  • cough
  • pancreatitis
  • constipation
Show 102 more
  • oral ulcer formation
  • rash
  • vesicular pemphigoid
  • severe and disabling arthralgia
  • rhabdomyolysis
  • weight gain
  • increased lipase
  • increased amylase
  • dyspepsia
  • edema
  • facial edema
  • peripheral edema
  • weight loss
  • increased appetite
  • constipation
  • abdominal pain
  • enterocolitis
  • intestinal obstruction
  • gastritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech disorder
  • Alzheimer's dementia
  • chest pain
  • fever
  • facial edema
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • gastric cancer
  • rectal cancer
  • pancreatic cancer
  • meniscus injury
  • pneumoconiosis
  • congestive heart failure
  • angina pectoris
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • kidney transplant failure
  • anemia
  • nausea
  • diarrhea
  • vomiting
  • gastroesophageal reflux disease
  • gastritis
  • dizziness
  • sensory impairment
  • pruritus
  • insomnia
  • depression
  • hypertension
  • benign prostatic hyperplasia
  • androgenetic alopecia
  • hyperhidrosis
  • hair loss
  • anxiety
  • bruise
  • bone bruise
  • concussion
  • bone fracture
  • hand fracture
  • laceration
  • palpitations
  • dry eyes
  • glaucoma
  • cataract
  • eye discomfort
  • allergic conjunctivitis
  • polyuria
  • proteinuria
  • stress urinary incontinence
  • hematuria
  • hypotension
  • flushing
  • hearing loss
  • erectile dysfunction
  • thyroid enlargement

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture, and it is safe to store it at room temperature between 1 to 30 degrees Celsius. Storing it this way maintains the effectiveness of the medication and prevents degradation.

Appearance and packaging

Appearance

Round film-coated tablets that are bright red in color, with both sides convex and sharp edges.

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.